Gene clustering analysis in human osseous remodeling

Journal of Periodontology

Volumn 80, Issue 12, 2009, Pages 1998-2009

  Sbordone, Ludovico ^a   Sbordone, Carolina ^b   Filice, Natalia ^a,c   Menchini Fabris, GiovanBattista ^a   Baldoni, Marco ^c   Toti, Paolo ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Alveolar ridge augmentation; Bone remodeling; Bone resorption; Computational biology; Endosseous dental implantation; Genomics

Indexed keywords

IL6 PROTEIN, HUMAN; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEIN C FOS; PROTEIN C JUN; RUNX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ALGORITHM; ARTICLE; BIOLOGY; BONE DEVELOPMENT; BONE REGENERATION; BONE REMODELING; BONE TRANSPLANTATION; DATA MINING; DISTRACTION OSTEOGENESIS; FORECASTING; GENETICS; HUMAN; MULTIGENE FAMILY; OSTEOLYSIS; TISSUE REGENERATION;

ALGORITHMS; BONE REGENERATION; BONE REMODELING; BONE RESORPTION; BONE TRANSPLANTATION; COMPUTATIONAL BIOLOGY; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DATA MINING; FORECASTING; GUIDED TISSUE REGENERATION; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MULTIGENE FAMILY; OSTEOGENESIS; OSTEOGENESIS, DISTRACTION; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 72749083649     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2009.090290     Document Type: Article

References (47)

1. Chiapasco M, Zaniboni M, Boisco M. Augmentation procedures for the rehabilitation of deficient edentulous ridges with oral implants. Clin Oral Implants Res 2006;17(Suppl. 2):136-159.
2. Willard HF, Angrist M, Ginsburg GS. Genomic medicine: Genetic variation and its impact on the future of health care. Philos Trans R Soc Lond B Biol Sci 2005;360:1543-1550.
3. Sivozhelezov V, Giacomelli L, Tripathi S, Nicolini C. Gene expression in the cell cycle of human T lymphocytes: I. Predicted gene and protein networks. J Cell Biochem 2006;97:1137-1150.
4. Nicolini C, Spera R, Stura E, Fiordoro S, Giacomelli L. Gene expression in the cell cycle of human T-lymphocytes: II. Experimental determination by DNASER technology. J Cell Biochem 2006;97:1151-1159.
5. Covani U, Marconcini S, Giacomelli L, Sivozhelevov V, Barone A, Nicolini C. Bioinformatic prediction of leader genes in human periodontitis. J Periodontol 2008;79:1974-1983.
6. Tibshirani R, Walther G, Hastie T. Estimating the number of clusters in a data set via gap statistic. J R Stat Soc, B 2001;63:411-423.
7. Fitzpatrick RB. ISI's Journal Citation Reports on the Web. Med Ref Serv Q 2003;22:45-56.
8. Hardesty RA, Marsh JL. Craniofacial onlay bone grafting: A prospective evaluation of graft morphology, orientation, and embryonic origin. Plast Reconstr Surg 1990;85:5-14; discussion 15.
9. Phillips JH, Rahn BA. Fixation effects on membranous and endochondral onlay bone graft revascularization and bone deposition. Plast Reconstr Surg 1990;85: 891-897.
10. Buchman SR, Ozaki W. The ultrastructure and resorptive pattern of cancellous onlay bone grafts in the craniofacial skeleton. Ann Plast Surg 1999;43:49-56.
11. Johansson B, Grepe A, Wannfors K, Hirsch JM. A clinical study of changes in the volume of bone grafts in the atrophic maxilla. Dentomaxillofac Radiol 2001;30:157-161.
12. Smolka W, Eggensperger N, Carollo V, Ozdoba C, Iizuka T. Changes in the volume and density of calvarial split bone grafts after alveolar ridge augmentation. Clin Oral Implants Res 2006;17:149-155.
13. Kirmeier R, Payer M, Wehrschuetz M, Jakse N, Platzer S, Lorenzoni M. Evaluation of three-dimensional changes after sinus floor augmentation with different grafting materials. Clin Oral Implants Res 2008;19: 366-372.
14. Jung RE, Thoma DS, Hammerle CHF. Assessment of the potential of growth factors for localized alveolar ridge augmentation: A systematic review. J Clin Periodontol 2008;35(Suppl. 8):255-281.
15. Geiger F, Lorenz H, Xu W, et al. VEGF producing bone marrow stromal cells (BMSC) enhance vascularization and resorption of a natural coral bone substitute. Bone 2007;41:516-522.
16. Peng H, Wright V, Usas A, et al. Synergistic enhancement of bone formation and healing by stem cellexpressed VEGF and bone morphogenetic protein-4. J Clin Invest 2002;110:751-759.
17. Mayer H, Bertram H, Lindenmaier W, Korff T, Weber H, Weich H. Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: Autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem 2005;95:827-839.
18. Wikesjö UM, Huang YH, Polimeni G, Qahash M. Bone morphogenetic proteins: A realistic alternative to bone grafting for alveolar reconstruction. Oral Maxillofac Surg Clin North Am 2007;19:535-551.
19. Lavery K, Swain P, Falb D, Alaoui-Ismaili MH. BMP-2/ 4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. J Biol Chem 2008;283:20948-20958.
20. Sowa H, Kaji H, Hendy GN, et al. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2. J Biol Chem 2004;279:40267-40275.
21. Majumdar MK, Wang E, Morris EA. BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. J Cell Physiol 2001;189:275-284.
22. Ortiz CO, Chen BK, Bale LK, Overgaard MT, Oxvig C, Conover CA. Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts. J Bone Miner Res 2003;18:1066-1072.
23. Wright N, de Lera TL, García-Moruja C, et al. Transforming growth factor-beta1 down-regulates expression of chemokine stromal cell-derived factor-1: Functional consequences in cell migration and adhesion. Blood 2003;102:1978-1984.
24. Carinci F, Palmieri A, Martinelli M, et al. Genetic portrait of osteoblast-like cells cultured on PerioGlas. J Oral Implantol 2007;33:327-333.
25. Baughn LB, Di Liberto M, Niesvizky R, et al. CDK2 phosphorylation of Smad2 disrupts TGF-beta transcriptional regulation in resistant primary bone marrow myeloma cells. J Immunol 2009;182:1810-1817.
26. Akira S, Hirano T, Taga T, Kishimoto T. Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J 1990;4:2860-2867.
27. Fioravanti A, Moretti E, Scapigliati G, Cervone R, Galeazzi M, Collodel G. Morphological, immunocytochemical and biochemical studies in human osteoarthritic chondrocytes exposed to IL-1b and cyclical hydrostatic pressure. Clin Exp Rheumatol 2007;25: 690-695.
28. Ihara H, Hirukawa K, Goto S, Togari A. ATP-stimulated interleukin-6 synthesis through P2Y receptors on human osteoblasts. Biochem Biophys Res Commun 2005;326:329-334.
29. Brubaker KD, Vessella RL, Brown LG, Corey E. Prostate cancer expression of runt-domain transcription factor Runx2, a key regulator of osteoblast differentiation and function. Prostate 2003;56:13-22.
30. Schroeder TM, Jensen ED, Westendorf JJ. Runx2: A master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res C Embryo Today 2005;75:213-225.
31. Komori T. Regulation of bone development and maintenance by Runx2. Front Biosci 2008;13:898-903.
32. Gilbert L, He X, Farmer P, et al. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/ Pebp2 aA) is inhibited by tumor necrosis factor-a. J Biol Chem 2002;277:2695-2701.
33. Wagner EF, Eferl R. Fos/AP-1 proteins in bone and the immune system. Immunol Rev 2005;208:126-140.
34. Takayanagi H, Kim S, Matsuo K, et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-b. Nature 2002;416:744-749.
35. Doi M, Nagano A, Nakamura Y. Genome-wide screening by cDNA microarray of genes associated with matrix mineralization by human mesenchymal stem cells in vitro. Biochem Biophys Res Commun 2002;290:381-390.
36. Kulterer B, Friedl G, Jandrositz A, et al. Gene expression profiling of humanmesenchymal stemcells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics 2007;8:70-84.
37. Feng C, Araki M, Kunimoto R, Tamon A, Makiguchi H, Niijima S, Tsujimoto G, Okuno Y. GEM-TREND: A web tool for gene expression data mining toward relevant network discovery. BMC Genomics 2009;10:411.
38. Halle M, Berg A, Northoff H, Keul J. Importance of TNF-alpha and leptin in obesity and insulin resistance: A hypothesis on the impact of physical exercise. Exerc Immunol Rev 1998;4:77-94.
39. Palomo I, Alarcón M, Moore-Carrasco R, Argilés JM. Hemostasis alterations in metabolic syndrome. Int J Mol Med 2006;18:969-974.
40. Sethi G, Sung B, Aggarwal BB. TNF: A master switch for inflammation to cancer. Front Biosci 2008;13: 5094-5107.
41. Santos FR, Moysés RM, Montenegro FL, Jorgetti V, Noronha IL. IL-1beta, TNF-alpha, TGF-beta, and bFGF expression in bone biopsies before and after parathyroidectomy. Kidney Int 2003;63:899-907.
42. Haluska FG, Huebner K, Isobe M, Nishimura T, Croce CM, Vogt PK. Localization of the human JUN protooncogene to chromosome region 1p31-32. Proc Natl Acad Sci USA 1988;85:2215-2218.
43. Cuevas BD, Abell AN, Johnson GL. Role of mitogenactivated protein kinase kinase kinases in signal integration. Oncogene 2007;26:3159-3171.
44. Chung KC, Kim SM, Rhang S, Lau LF, Gomes I, Ahn YS. Expression of immediate early gene pip92 during anisomycin-induced cell death is mediated by the JNK- and p38-dependent activation of Elk1. Eur J Biochem 2000;267:4676-4684.
45. Deng Y, Ren X, Yang L, Lin Y, Wu X. A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell 2003;115:61-70.
46. Takatsuka H, Takemoto Y, Yamada S, et al. Similarity between eruptions induced by sulfhydryl drugs and acute cutaneous graft-versus-host disease after bone marrow transplantation. Hematology 2002;7:55-57.
47. Rifas L. Bone and cytokines: Beyond IL-1, IL-6 and TNF-alpha. Calcif Tissue Int 1999;64:1-7.